Newsroom

Keep up to date with the latest news from
URP, UW Madison and our Resident Companies.

Kenneth Poss, Morgridge’s newest investigator, studies how zebrafish can restore what is irreparable in humans — including damaged heart tissue. Because Kenneth Poss is a true Badger, born and raised in Green Bay, it’s only natural that his scientific journey begins with a fish story....

Despite their enormous size, elephants defy the odds by almost never getting cancer. This paradox is still a mystery to scientists. It’s also a source of inspiration for a promising new Wisconsin spinoff company, Elephas Biosciences, which has created a platform to predict whether patients...

Two University of Wisconsin–Madison researchers are among 126 scientists across the United States and Canada selected as Sloan Research Fellows. UW–Madison’s 2025 Sloan Fellows are James Roberts Crall, assistant professor of entomology, and Sharon Yixuan Li, assistant professor of computer sciences....

Yet there are some aspects of the local market that could be improved, especially the development of a more robust population of mid-sized companies, according to Craig Stanley, founding principal of Broadwing Advisors. Broadwing is a commercial real estate advisory service that has worked with...

Early-career scientists are essential to the Morgridge mission, and the majority have some level of competitive support from NIH. Here, early-career researchers share thoughts on how federal funding supports their mission to conduct high-impact research....

“What’s really setting Axio apart is that we’re using AI at the foundation of the company, specifically we’re using AI in the process development cycle,” said Byers, who previously worked as a process development scientist....

After the NIH on Friday announced cuts to grants that help cover indirect R&D costs for medical research institutions, the Tech Council sent a statement to Wisconsin’s federal lawmakers warning the move will “cause immediate and likely lasting harm” to biomedical research in Wisconsin and...

At the Universities of Wisconsin Board of Regents meeting on Feb. 7, a panel of entrepreneurs, university leaders and business experts made a case for why founders – the individuals who create and build companies — must be the focus of UW–Madison’s evolving approach to...

He discusses the company’s focus on “molecular residual disease” to assess the effectiveness of various treatments for cancer or other diseases. The name eMBR Genomics — pronounced like ember — references mid-body remnants, a leftover cellular material linked to cell division....

In new research published in Science Advances, a team of researchers developed a method that uses nanoflow-based multiomic single-shot technology (nMOST) to profile both proteins and lipids simultaneously. The collaboration was led by Joshua Coon, the Thomas and Margaret Pyle Chair in metabolism at the...

A unique arrangement that could advance an affordable housing development near University Research Park could be replicated elsewhere, but perhaps not as frequently as some might hope. That arrangement has allowed a long-awaited, $63 million affordable housing development from Milwaukee’s Mandel Group to gain some...